BETTERLIFE PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

BETTERLIFE PHARMA INC. (BETRF) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding of $2.29 million as of 2017-10-31, per its 10-Q filed 2017-12-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding · last filed 2017-12-15

2017-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $2.29M.
2017-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $1.59K.
2017-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $203.14K.
2017-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $68.60K.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
2017-10-31	$2.29M 10-Q · filed 2017-12-15
2017-07-31	$1.59K 10-Q · filed 2017-09-15
2017-04-30	$203.14K 10-Q · filed 2017-06-13
2017-01-31	$68.60K 10-Q · filed 2017-12-15
2016-10-31	$36.00K 10-Q · filed 2016-12-12
2016-07-31	$200.00K 10-Q · filed 2016-09-12
2016-04-30	$4.93M 10-Q · filed 2016-06-14
2016-01-31	$4.93M 10-Q · filed 2016-12-12
2014-01-31	$4.93M 10-K/A · filed 2016-06-07